Background Genentech is the proprietor of European patent (UK) No. 1 641 822 entitled “Il-17A/F heterologous peptides and therapeutic uses thereof”. Genentech does not at present have a product covered by the patent but Lilly market an antibody under the...
Introduction This case relates to a European patent (EP2269603) in the name of Novartis relating to derivatives of rapamycin. Claim 1 of the patent covers: “40-O-(2-hydroxyethyl)-rapamycin in combination with exemestane for use in the treatment of hormone...
Background Ice-World, who is the proprietor of European patent No. 1462755, makes mobile ice rinks and leases them to third parties. Icescape also design and make mobile ice rinks, although in the past have operated a mobile ice rink leased to them from Ice-World....
Warner-Lambert originally developed its compound pregabalin, which it sold under the mark Lyrica, as an anti-convulsant, anti-anxiety, anti-psychotic medication, in particular for the treatment of epilepsy and generalised anxiety disorder. It obtained patent...
Gilead was the owner of an SPC for a combination of two actives, namely tenofovir and emtricitabine, which they market as Truvada®, which Teva and others wished to revoke. Interestingly, Gilead also sells tenofovir alone in the absence of an SPC. In accordance with...
Patents, Supplementary Protection Certificates (SPCs) and the Unitary Patent Court (UPC) Trade Marks and Designs Copyright Exhaustion of Rights Please click on one of the hyperlinks above to go to the particular guidance note. The overarching intention of the...
Recent Comments